Lung-I Cheng is Vice President of Cell and Gene Therapy. He is responsible for leading a unified CGT go-to-market strategy that addresses external customer needs and provides integrated solutions that deliver the right resources at the right time to position therapies for success. Before joining Cencora, he spent a decade in biopharma and most recently led Takeda Oncology’s global value and access team in cell therapies and pipeline.